In adults with acute HF, high-intensity care vs. usual care reduced a composite of death or HF readmission at 180 d
- PMID: 36877970
- DOI: 10.7326/J23-0005
In adults with acute HF, high-intensity care vs. usual care reduced a composite of death or HF readmission at 180 d
Abstract
Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400:1938-52. 36356631.
Comment on
-
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.Lancet. 2022 Dec 3;400(10367):1938-1952. doi: 10.1016/S0140-6736(22)02076-1. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356631 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous